Skip to content
207.878.2770mail@immucell.com
Immucell
Immediate Immunity™
Immucell
  • About ImmuCell
    • About ImmuCell
    • Our Purpose
    • Management and Directors
    • Contact Us
  • First Defense
    • First Defense® Tri-Shield and First Defense for Scours
    • Testimonials
  • Purified Nisin
    • Purified Nisin for Mastitis
    • CMT for Mastitis
  • Sales & Distributors
  • Resources
  • News
  • Investors
  • About ImmuCell
    • About ImmuCell
    • Our Purpose
    • Management and Directors
    • Contact Us
  • First Defense
    • First Defense® Tri-Shield and First Defense for Scours
    • Testimonials
  • Purified Nisin
    • Purified Nisin for Mastitis
    • CMT for Mastitis
  • Sales & Distributors
  • Resources
  • News
  • Investors
STOCK QUOTE
PRESS RELEASES

2018 | 2017 | 2016 | 2015 | 2014

SEC FILINGS
SEC FIlings

XBRL Documents

Annual Report and Proxy
CORPORATE GOVERNANCE
ICCC Code of Conduct

Charter and Powers of the Audit Committee

Management & Directors

Recent News

2018  |  2017  |  2016  |  2015  |  2014

02-08-18 ImmuCell Announces Preliminary Financial Results for Fourth Quarter and Full Year 2017

02-06-18 ImmuCell to Announce Financial Results for Fourth Quarter and Full Year 2017

01-30-18 ImmuCell Appoints Two New Members to its Board of Directors

COMPANY CONTACT

Michael F. Brigham
President & CEO
mail@immucell.com
207.878.2770

INVESTOR CONTACT
Lytham Partners, LLC
iccc@lythampartners.com
602.889.9700
Contact Us

56 Evergreen Drive
Portland, ME 04103

Office: 207.878.2770
Sales: 1.800.IMMUCELL
mail@immucell.com

NASDAQ: ICCC

Recent News

02-08-18 ImmuCell Announces Preliminary Financial Results for Fourth Quarter and Full Year 2017

02-06-18 ImmuCell to Announce Financial Results for Fourth Quarter and Full Year 2017

01-30-18 ImmuCell Appoints Two New Members to its Board of Directors

12-21-17 ImmuCell Corporation Announces Closing of $3 Million Public Offering of Common Stock

 

Follow Us

Find us on:

FacebookYouTube
Copyright © 2017 ImmuCell Corporation
  • Home
  • About ImmuCell
  • First Defense
  • Purified Nisin
  • Sales & Distributors
  • Resources
  • News
  • Investors
  • Contact Us
Footer Menu
Go to Top